IR Press

PTA-News: Dr. Hönle AG: Hönle increases its operating result by 113.6% to € 4.5 million in the first quarter

/

Gilching (pta025/22.02.2022/11:00) – In the first quarter of financial year 2021/2022, the Hönle Group’s revenues rose by 25.3% to T€ 33,418 compared to the prior year quarter. Both the Equipment & Systems and Glass & Lamps segments recorded significant revenue increases. A changed product mix and the lower proportion of sales from adhesives led to a higher cost of materials ratio in the first quarter. Nevertheless, Hönle managed to increase its operating result (EBIT) from T€ 2,119 in the previous year to T€ 4,526 in the reporting year. The operating result includes income of T€ 1,825 from the sale of the corporate building of former Aladin GmbH in Rott am Inn. The pre-tax result (EBT) came to T€ 4,189 after T€ 1,973 in the prior year period. Consolidated profit amounted to T€ 3,198 after income taxes, corresponding to an increase of 96.8%. Earnings per share rose from € 0.27 to € 0.53. The net profit on sales was thus 9.5% in the first quarter (PY: 6.1%).

PTA-Adhoc: Dr. Hönle AG: Hönle Group generates adjusted operating profit of EUR 7.9 million

/

Gilching (pta032/01.12.2021/14:55) – The Hönle Group benefited from the economic upturn and was able to significantly increase its sales and, above all, its incoming orders. In addition, the new group companies made a significant contribution to the expansion of business activities. According to preliminary figures, sales in the 2020/2021 financial year increased by 22.7% to € 115.2 million compared to the previous year. The order backlog of the Hönle Group made a strong jump and was around 80% above the previous year’s level at the end of the financial year.

PTA-Adhoc: Dr. Hönle AG: Hönle takes non-cash impairment into account in the 2020/2021 financial year – outlook remains positive

/

Gilching (pta040/24.11.2021/18:30) – The assumptions made as part of the planning and now adjusted for the business development of a subsidiary of Dr. Hönle AG leads to non-cash impairment losses in the group in the fourth quarter. The impairments relate to goodwill in the amount of 3.4 million euros and other items on the assets side of the balance sheet in the amount of 4.1 million euros. The impairments essentially result from the assumption that the sales of Raesch Quarz (Germany) GmbH in the existing sales markets will grow more slowly in the next five years than originally planned. The impairment test carried out resulted in an impairment requirement, since the future achievable income is below the book value of the cash-generating unit. The goodwill of Raesch Quarz (Germany) GmbH is written down in full.

PTA-Adhoc: Dr. Hönle AG: Hönle adjusts outlook for the past financial year and gives outlook for the new financial year

/

Gilching (pta029/06.10.2021/17:20) – The move of the Dr. Hönle AG in the new company building resulted in less production and delivery than planned in the fourth quarter. In addition, long delivery times for electronic components, mechanical components and, in some cases, raw materials at the Hönle Group led to bottlenecks on the procurement side. This contributed significantly to the postponement of delivery dates from the past fiscal year to the new fiscal year. The Management Board therefore assumes that the operating result in the 2020/2021 financial year will be almost at the previous year’s level. Originally, the Management Board had assumed a significant improvement in earnings compared to the previous year.

PTA-News: Dr. Hönle AG: Sales increase in the 9-month period by 18.4% to EUR 84.9 million

/

Gräfelfing/München (pta007/06.08.2021/08:05) – Revenues earned by the Hönle Group in the 9-month period climbed from T€ 71,734 in the previous year to T€ 84,932 in the current financial year. The following factors led to a slowdown in the Hönle Group’s business development in the current financial year: The Corona crisis had a dampening effect in individual sectors such as the printing press market where revenues generated in the first nine months of financial year 2020/2021 were significantly below the previous year’s level. Moreover, there were supply bottlenecks on the procurement side. Long delivery times for raw materials, electronic components and, in some cases, mechanical components resulted in delivery dates being postponed from the third quarter to the fourth quarter.

PTA-Adhoc: Dr. Hönle AG: The promotion of mobile air disinfection systems provides excellent growth opportunities for Hönle

/

Gräfelfing/München (pta029/15.07.2021/14:40) – According to preliminary figures, Hönle Group sales revenues increased from Eur 71.7 million to Eur 84.9 million in the nine-month period. The operating result (EBIT) climbed from Eur 6.3 million to Eur 7.3 million. Adverse effects weighted on the Hönle Group’s business development in the current financial year: In some individual sectors such as the printing press market, the dampening effects of the Corona crisis were still being felt with sales in the first nine months of the 2020/2021 financial year being significantly below the previous year’s level. Moreover, there were supply bottlenecks on the procurement side. Long delivery times for raw materials, electronic components and in some cases also for mechanical components led to the postponement of delivery dates from the third quarter to the fourth quarter.

Scroll to Top